Class Action Lawsuit
Zicam Recall Lawsuit
Zicam Class Action Lawsuit
On April 7, 2010 Attorney Joseph H. Saunders was appointed by the U.S. District Court in Phoenix, Arizona to serve on the Plaintiffs Steering Committee in the Zicam Cold Remedy Marketing, Sales Practices and Product Liability Litigation MDL 2096.
After numerous reports and complaints from readers and our own investigation into complaints of loss of smell as a result of using Zicam products, the FDA, today announced a warning recall on several Zicam products related to loss of smell.
As always doihavealawsuit.com has been at the forefront on this and our associated attorneys are waiting by the phone and their email boxes to answer your questions.
If you are not familiar with the lawsuit process please feel free to call the lead class action lawsuit firm directly and they will provide you with a free case evaluation. You may also contact the lead attorney directly by calling (800) 748-7115 or by clicking here and filling out the short lawsuit contact form found by clicking here or from the homepage of doihavealawsuit.com
FDA Advises Consumers Not To Use Certain Zicam Cold Remedies
Intranasal Zinc Product Linked to Loss of Sense of Smell
The U.S. Food and Drug Administration today advised consumers to stop using three products marketed over-the-counter as cold remedies because they are associated with the loss of sense of smell (anosmia). Anosmia may be long-lasting or permanent.
The products are:
--Zicam Lawsuit Cold Remedy Nasal Gel
--Zicam Lawsuit Cold Remedy Nasal Swabs
--Zicam Lawsuit Cold Remedy Swabs, Kids Size (a discontinued product)
The FDA has received more than 130 reports of loss of sense of smell associated with the use of these three Zicam products. In these reports, many people who experienced a loss of smell said the condition occurred with the first dose; others reported a loss of the sense of smell after multiple uses of the products.
“Loss of sense of smell is a serious risk for people who use these products for relief from cold symptoms,” said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research (CDER). “We are concerned that consumers may unknowingly use a product that could cause serious harm, and therefore we are advising them not to use these products for any reason.”
People who have experienced a loss of sense of smell or other problems after use of the affected Zicam products should contact their health care professional. The loss of sense of smell can adversely affect a person’s quality of life, and can limit the ability to detect the smell of gas or smoke or other signs of danger in the environment.
The FDA has issued Matrixx Initiatives, maker of these Zicam products, a warning letter telling it that these products cannot be marketed without FDA approval.
“Companies have an obligation to the public to demonstrate to the FDA that their products are safe, particularly when there is evidence they may be causing serious adverse events, and they are marketed for minor, self-limiting conditions like the common cold,” said Deborah M. Autor, director of CDER’s Office of Compliance.